Final results of PRODIGE 9, a randomized phase III comparing no treatment to bevacizumab maintenance during chemotherapy-free intervals in metastatic colorectal cancer.

被引：3

作者：

Aparicio, Thomas

Bennouna, Jaafar

Le Malicot, Karine

Ghiringhelli, Francois

Boige, Valerie

Taieb, Julien

Bouche, Olivier

Phelip, Jean Marc

Francois, Eric

Borel, Christian

Faroux, Roger

Seitz, Jean-Francois

Jacquot, Stephane

Genet, Dominique

Khemissa, Faiza

Suc, Etienne

Desseigne, Francoise

Texereau, Patrick

Jouve, Jean-Louis

机构：

[1] Hop Avicenne, AP HP, Bobigny, France

[2] Inst Cancerol Ouest Site Rene Gauducheau, St Herblain, France

[3] FFCD, Dijon, France

[4] Ctr Georges Francois Leclerc, Dijon, France

[5] Gustave Roussy, Serv Oncol Digest, Villejuif, France

[6] Hop Europeen Georges Pompidou, Paris, France

[7] CHU Robert Debre, Reims, France

[8] CHU Nord, St Etienne, France

[9] Ctr Antoine Lacassagne, Dept Med Oncol, Nice, France

[10] Paul Strauss Ctr, Dept Oncol, Strasbourg, France

[11] Ctr Hosp Dept Oudairies, La Roche Sur Yon, France

[12] APHM Timone, Marseille, France

[13] CLIN PRIVEE CLEMENTVILLE, Dept Radiotherapy & Oncol, Montpellier, France

[14] ARCH Polyclin Limoges, Limoges, France

[15] CH St Jean, Perpignan, France

[16] Clin St Jean Languedoc, Dept Oncol, Toulouse, France

[17] Ctr Leon Berard, Lyon, France

[18] Hop Layne, Dept Hepato Gastroenterol, Mont De Marsan, France

[19] Univ Hosp, Dijon, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.3531

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3531

引用

页数：2